From GlobeNewswire: 2025-05-06 13:40:00

Cosmos Health Inc. (NASDAQ:COSM) has been granted an additional 180-day period by Nasdaq to regain compliance with the minimum bid price requirement, extending until November 3, 2025. The company was initially notified of non-compliance on November 6, 2024, due to the stock price falling below $1.00 for 30 consecutive days. Cosmos Health remains focused on meeting listing requirements and is confident in its ability to regain compliance within the extended timeframe. The CEO, Greg Siokas, expressed gratitude for Nasdaq’s support and reiterated the company’s commitment to delivering long-term value for shareholders.

Cosmos Health Inc., a global healthcare group, owns various pharmaceutical and nutraceutical brands, operates a telehealth platform, and manufactures healthcare products. Through subsidiary Cana Laboratories S.A., the company produces pharmaceuticals, supplements, cosmetics, and medical devices in the European Union. Cosmos Health also distributes pharmaceuticals and parapharmaceuticals in Greece and the UK, focusing on R&D partnerships for health disorders like obesity and diabetes. The company is expanding globally and recently acquired ZipDoctor, Inc. in the telehealth space. More information is available on their website.



Read more at GlobeNewswire: Cosmos Health Receives Additional 180-Day Compliance Period